OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.
Okyo Pharma stock last closed at $1.17, down 4.1% from the previous day, and has decreased 13.97% in one year. It has overperformed other stocks in the Biotechnology industry by 0.64 percentage points. Okyo Pharma stock is currently +44.98% from its 52-week low of $0.81, and -32.76% from its 52-week high of $1.74.
As of Apr 21, 2025, there are 33.94M shares of OKYO outstanding. The market cap of OKYO is $39.71M. In the last 24 hours, 12,969 OKYO shares were traded.
You will need a brokerage account to access the NASDAQ market and buy OKYO stock.
In our opinion, eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, it's time to fill out some personal information so you can buy OKYO stock today.
Now that you have created your account on the best stock broker app, you need to deposit funds:
Watch this video walkthrough for more details depositing funds into your new investment account.
Once you have identified the best place to buy Okyo Pharma stock, it's crucial to evaluate their stock prior to buying, so you actually wrap your head around the risk and upside.
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on OKYO's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge OKYO's fair value.
You can access more valuation analysis on OKYO's stock here.
Out of 1 sell side analysts who monitor OKYO, the consensus analyst rating on Okyo Pharma is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Okyo Pharma stock forecast page.
Over the last 12 months, executives and large shareholders at OKYO have not bought or sold any shares.
Learn more about who owns OKYO shares here.
No, Okyo Pharma doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two primary types of orders:
Hit the Open button and eToro will execute your order.
If you want additional info about investing in stocks on eToro, click the how to video below:
Now that you own some OKYO shares, you'll want to stay up-to-date on your investment.
Make a watchlist to keep track of your OKYO stock.
To reiterate, here are the 6 steps to buy Okyo Pharma stock:
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to watch your new investment in Okyo Pharma, create your watchlist below.